Michael Raab Ardelyx, Inc. (ARDX) insider trading activity

Michael Raab is President & CEO of ARDELYX, INC.. Currently has a direct ownership of 1.18 Million shares of ARDX, which is worth approximately $6.11 Million. The most recent transaction as insider was on Jan 16, 2024, when has been sold 475,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.18M

4.21% 3M change

35.43% 12M change

Total Value Held $6.11 Million

MICHAEL RAAB Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 16 2024	BUY Grant, award, or other acquisition	-	475,000 Added 26.13%	1,342,868 Common Stock
Nov 20 2023	SELL Open market or private sale	$49,564 $4.36 p/Share	11,368 Reduced 1.29%	867,868 Common Stock
Aug 21 2023	SELL Open market or private sale	$40,537 $3.55 p/Share	11,419 Reduced 1.29%	876,236 Common Stock
May 23 2023	SELL Open market or private sale	$41,453 $3.65 p/Share	11,357 Reduced 1.26%	887,655 Common Stock
Feb 21 2023	SELL Open market or private sale	$40,347 $3.0 p/Share	13,449 Reduced 1.48%	896,012 Common Stock
Jan 05 2023	BUY Grant, award, or other acquisition	-	250,000 Added 21.56%	909,461 Common Stock
Nov 22 2022	SELL Open market or private sale	$12,064 $1.94 p/Share	6,219 Reduced 0.93%	659,461 Common Stock
Aug 31 2022	BUY Open market or private purchase	$1,860 $0.62 p/Share	3,000 Added 0.45%	665,680 Common Stock
Aug 22 2022	SELL Open market or private sale	$6,023 $0.98 p/Share	6,146 Reduced 0.92%	662,680 Common Stock
Jun 06 2022	SELL Open market or private sale	$67,356 $0.65 p/Share	103,624 Reduced 13.41%	668,826 Common Stock
May 20 2022	SELL Open market or private sale	$4,103 $0.67 p/Share	6,124 Reduced 0.79%	772,450 Common Stock
Feb 22 2022	SELL Open market or private sale	$4,173 $0.67 p/Share	6,229 Reduced 0.8%	775,574 Common Stock
Jan 06 2022	BUY Grant, award, or other acquisition	-	150,000 Added 16.1%	781,803 Common Stock
Nov 22 2021	SELL Open market or private sale	$2,581 $0.99 p/Share	2,607 Reduced 0.41%	631,803 Common Stock
Oct 08 2021	BUY Grant, award, or other acquisition	-	300,000 Added 32.11%	634,410 Common Stock
Aug 20 2021	SELL Open market or private sale	$3,396 $1.32 p/Share	2,573 Reduced 0.77%	329,730 Common Stock
Aug 03 2021	SELL Payment of exercise price or tax liability	$246,563 $1.64 p/Share	150,343 Reduced 31.15%	332,303 Common Stock
Aug 03 2021	BUY Exercise of conversion of derivative security	$144,662 $0.54 p/Share	267,892 Added 35.69%	482,646 Common Stock
May 20 2021	SELL Open market or private sale	$17,966 $7.09 p/Share	2,534 Reduced 1.17%	214,754 Common Stock
Feb 22 2021	SELL Open market or private sale	$17,434 $6.88 p/Share	2,534 Reduced 1.15%	217,288 Common Stock
Jan 05 2021	BUY Grant, award, or other acquisition	-	115,102 Added 34.37%	219,822 Common Stock

Also insider at

FOLD

AMICUS THERAPEUTICS, INC. Healthcare

TPST

Tempest Therapeutics, Inc. Healthcare

Michael Raab

President & CEO

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARDX shares.

Notify only if

Value

Insider Trading

Get notified when an Ardelyx, Inc. insider buys or sells ARDX shares.

Notify only if

Operation

Value

Type

News

Receive news related to ARDELYX, INC.

Track Activities on ARDX

Account